Evidence map›Paper›PMID 26989401›Full record

ArticleCardiorenal medicine2016

Association between Plaque Score of the Carotid Artery and the Severity of Sleep Apnea Syndrome in Patients with Chronic Kidney Disease.

Daisuke Hasegawa, Akihito Tanaka, Daijo Inaguma, Eri Ito, Naoki Kamegai, Akiko Kato, Minami Mizutani, Hiroya Shimogushi, Hibiki Shinjo, Yasuhiro Otsuka and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiorenal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Daisuke HasegawaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Akihito TanakaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Daijo InagumaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Eri ItoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Naoki KamegaiKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Akiko KatoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Minami MizutaniKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Hiroya ShimogushiKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Hibiki ShinjoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Yasuhiro OtsukaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Asami TakedaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Japanese Red Cross Nagoya Daini Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, sleep apnea syndrome (SAS) has been associated with hypertension, cardiovascular disease and death. Patients with chronic kidney disease (CKD) have higher rates of SAS, atherosclerotic complications and death than do patients without CKD. Although the relationship between SAS and atherosclerosis is well known, few papers have described this relationship in humans, especially in CKD patients. PATIENTS AND

methodsThis was a cross-sectional study of 110 clinically stable, non-dialysis patients with CKD who attended a CKD educational program from April 2014 to September 2015. The diagnosis of SAS and its severity were assessed using a type 3 portable monitor. Other atherosclerosis-related data were obtained from the patients' medical records in order to determine the factors associated with the severity of SAS.

results95 men and 15 women with a mean age of 71.4 ± 9.9 years were included in the study. The patients' mean body mass index was 24.0 ± 3.9, their mean blood pressure 134.3 ± 21.2/73.6 ± 13.4 mm Hg and their mean estimated glomerular filtration rate 19.8 ± 9.5 ml/min/1.7 m(2). Adjusted plaque score was a significant predictor of severe SAS (odds ratio = 1.13, p = 0.0182). Mixed plaque was significantly associated with severe SAS (correlation ratio = 0.48, p < 0.0001).

conclusionsMany patients with CKD also have SAS. Our findings demonstrate the relationship between plaque score and the severity of SAS.

Indexed as

Apnea-hypopnea indexAtherosclerosisCardiovascular diseaseChronic kidney diseaseEstimated glomerular filtration ratePlaque scoreSleep apnea syndromeSystolic function

Identifiers

PMID26989401
PMCPMC4789906
OpenAlexW2300290681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.